Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-20-061174

President and CEO acquired 4,263 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Domzalski David · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-11-30 Grant or award : show line 1 in the form +4,263 $1.45 $6,160 1,313,990 D
Loading xslF345X03/doc4.xml…